Lantern PharmaLTRN
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 31 institutions reported holding Lantern Pharma Inc. (LTRN) in their 13F filings, down 8 from Q2 2024. 3 opened new positions and 11 sold out. The largest holders were Vanguard Group Inc. ($1.3M), CM Management, LLC ($679K) and NewEdge Advisors, LLC ($504K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lantern Pharma Inc.
- CUSIP
- 51654W101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $115K |
| Exits | 11 | $287K |
All 13F filers, Q2 2024 → Q3 2024: 180,633 shares bought and 131,437 shares sold, net +49,196 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Vanguard Group Inc. | 0.00% | No change | 363,720 | $1.3M |
| CM Management, LLC | 0.54% | Add +131.3% | 185,000 | $679K |
| NewEdge Advisors, LLC | 0.00% | Reduce -12.6% | 137,338 | $504K |
| Geode Capital Management, LLC | 0.00% | Add +1.3% | 87,435 | $321K |
| Renaissance Technologies | 0.00% | Add +2.7% | 84,000 | $308K |
| DAVENPORT & Co LLC | 0.00% | Reduce -15.7% | 53,814 | $197K |
| BlackRock, Inc. | 0.00% | — | 40,480 | $149K |
| Redmond Asset Management, LLC | 0.04% | Reduce -1.8% | 38,920 | $143K |
| Dimensional Fund Advisors LP | 0.00% | Add +103.9% | 37,548 | $138K |
| Two Sigma Investments, LP | 0.00% | Reduce -1.3% | 34,340 | $126K |
| Westside Investment Management, Inc. | 0.02% | Add +166.5% | 30,650 | $112K |
| Perigon Wealth Management, LLC | 0.00% | New | 28,900 | $106K |
| Sigma Planning Corp | 0.00% | Add +0.9% | 28,650 | $105K |
| Horizon Kinetics Asset Management LLC | 0.00% | Reduce -4.2% | 27,582 | $101K |
| UBS Group AG | 0.00% | Add +5.4% | 26,871 | $99K |
| Bank of New York Mellon Corp | 0.00% | No change | 26,482 | $97K |
| State Street Corp. | 0.00% | No change | 23,652 | $87K |
| Susquehanna International Group, LLP | 0.00% | Reduce -63.4% | 21,881 | $80K |
| Tocqueville Asset Management L.P. | 0.00% | No change | 17,000 | $62K |
| Northern Trust Corp. | 0.00% | No change | 12,813 | $47K |
| Avantax Planning Partners, Inc. | 0.00% | No change | 11,640 | $43K |
| Wells Fargo & Company | 0.00% | Add +13.5% | 8,008 | $29K |
| Simplex Trading, LLC | 0.00% | Reduce -3.0% | 3,104 | $11K |
| Citadel Advisors | 0.00% | New | 2,153 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +13.1% | 1,515 | $6K |
| Indiana Trust & Investment Management Co | 0.00% | No change | 750 | $3K |
| Wolff Wiese Magana LLC | 0.00% | No change | 600 | $2K |
| Morgan Stanley | 0.00% | No change | 600 | $2K |
| Parkside Financial Bank & Trust | 0.00% | New | 260 | $955 |
| Allworth Financial LP | 0.00% | No change | 100 | $367 |
| Bank of America Corp. | 0.00% | Reduce -5.8% | 65 | $239 |
"% of holder's portfolio" is LTRN's weight in each manager's 13F, not the share of Lantern Pharma Inc. the manager owns.